Neurophysiology and Rehabilitation (ISSN: 2641-8991)

Neurophysiology and Rehabilitation (ISSN: 2641-8991)

Explore journal overview, editorial leadership, indexing, articles in press, latest published work, and highlights from previous issues.

Neurophysiology and Rehabilitation (ISSN: 2641-8991)

Donepezil

Neurophysiology and Rehabilitation journal | Donepezil Research articles | Open access Alzheimers disease

Donepezil is a medication used to treat Alzheimers disease. Common side effects include nausea, trouble sleeping, aggression, diarrhea, muscle cramps and feeling tired. Serious side effects may include heart arrythmias, urinary retention, and seizures. Donepezil is a centrally acting reversible acetyl cholinesterase inhibitor.

Donepezil should be used with caution in people with heart disease, cardiac conduction disturbances, chronic obstructive pulmonary disease, asthma, severe cardiac arrhythmias and sick sinus syndrome.

Donepezil binds and reversibly inactivates the cholinesterases, thus inhibiting hydrolysis of acetylcholine. This increases acetylcholine concentrations at cholinergic synapses

Researchers, authors, reviewers, and readers can use this page to find journal resources connected with Donepezil, including published articles, related academic topics, current issue content, archive material, and manuscript submission information.

Related Articles

Related article links for Donepezil will appear here as matching content is published in Neurophysiology and Rehabilitation (ISSN: 2641-8991). Readers can also browse the journal archive and current issue for connected research.

More Topics in This Journal

Neurophysiology and Rehabilitation (ISSN: 2641-8991)

Subscribe for updates

Subscribe

to get latest updates.


  Life Science

  Health Science

  Chemical Science


Subscribe